CARDIODX INC
Profile
Company Names
CARDIODX INC
Addresses
600 SAGINAW DRIVE, REDWOOD CITY, CA 94063
600 SAGINAW DR., REDWOOD CITY, CA 94063
2500 FABER PLACE, PALO ALTO, CA 94303
Phone Numbers
(650) 475-2788
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$174,043,589.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2017-01-05
$18,125,400.00
$41,753,500.00
$23,628,100.00
Equity
5
2015-06-17
$12,369,483.00
$25,500,912.00
$13,131,429.00
Equity
4
2014-07-19
$20,983,348.00
$24,999,996.00
$4,016,648.00
Equity
3
2012-08-16
$30,509,397.00
$58,018,795.00
$27,509,398.00
Equity
2
2011-02-17
$57,491,448.00
$78,325,737.00
$20,834,289.00
Equity
1
2010-05-06
$34,564,513.00
$44,536,736.00
$9,972,223.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
BROOK
BYERS
DIRECTOR
OPTIMEDICA CORP
| HX DIAGNOSTICS INC
| CRESCENDO BIOSCIENCE, INC.
| CARDIODX INC
| VERACYTE, INC.
| FIVE PRIME THERAPEUTICS INC
| XDX, INC.
| ELCELYX THERAPEUTICS, INC.
| FOUNDATION MEDICINE, INC.
| OCULEVE, INC.
| ENJOY TECHNOLOGY, INC.
| ZEPHYR HEALTH, INC.
| NEWSELA, INC.
| CAREDX, INC.
| CELL DESIGN LABS, INC.
| GRAIL, INC.
| OCTAVE BIOSCIENCE INC
| EPIODYNE, INC.
| ARSENAL BIOSCIENCES, INC.
FRED
COHEN
DIRECTOR
PROTEOGENIX INC
| NODALITY INC
| NODALITY, INC.
| QUINTILES TRANSNATIONAL HOLDINGS INC.
| CARDIODX INC
| VERACYTE, INC.
| FIVE PRIME THERAPEUTICS INC
| XDX, INC.
| NOVAQUEST HEALTHCARE INVESTMENT FUND, L.P.
| REVAL HOLDINGS INC
| NOVAQUEST HEALTHCARE INVESTMENT FUND III, L.P.
| BNA CHICAGO LLC
| NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.
| ROKA BIOSCIENCE, INC.
| RAPID MICRO BIOSYSTEMS, INC.
| AUXOGYN, INC.
| CAREDX, INC.
| PROGYNY, INC.
| CELL DESIGN LABS, INC.
| CHICKEN SOUP FOR THE SOUL ENTERTAINMENT, INC.
| VIDA VENTURES, LLC
| VVAG SPECIAL FUND LLC
| ASKLEPIOS BIOPHARMACEUTICAL, INC.
| VV ATREUS SPECIAL FUND LLC
| VIDA VENTURES II, LLC
| VIDA VENTURES II-A, LLC
| ASCEND GENE + CELL THERAPIES LTD.
| FIREFLY NEUROSCIENCE, INC.
| KYVERNA THERAPEUTICS, INC.
| ASCEND ADVANCED THERAPIES GROUP, INC.
| OLLIN BIOSCIENCES, INC.
PATRICK
ENRIGHT
DIRECTOR
XANODYNE PHARMACEUTICALS INC
| CARDIODX INC
| LONGITUDE VENTURE PARTNERS II, L.P.
| INFACARE PHARMACEUTICAL CORP
| ESPERION THERAPEUTICS, INC.
| ALLERGEN RESEARCH CORP
| SUTROVAX, INC.
| ORBUS THERAPEUTICS, INC.
| LONGITUDE VENTURE PARTNERS III, L.P.
| ROCK STARR LLC
| ROCKPOINT LLC
| APTINYX INC.
| CURASEN THERAPEUTICS, INC.
| STICHTING ADMINISTRATIEKANTOOR SYNCREON
| VERA THERAPEUTICS, INC.
| RIVUS PHARMACEUTICALS, INC.
| LONGITUDE VENTURE PARTNERS V, L.P.
| LONGITUDE PRIME FUND II, L.P.
| BIOAGE LABS, INC.
| VERADERMICS, INC
| LONGITUDE 103.8 EAST, L.P.
| INFINANT HEALTH, INC.
PATRICK
G.
ENRIGHT
DIRECTOR
WILLIAM
ERICSON
DIRECTOR
MICHAEL
GOLDBERG
DIRECTOR
IRHYTHM TECHNOLOGIES INC
| MDV IX LP
| CRESCENDO BIOSCIENCE, INC.
| CORVENTIS INC
| CIVICSOLAR, INC
| CARDIODX INC
| ALLIQUA, INC.
| CORNOVA INC
| DNANEXUS, INC.
| COGNOTION, INC.
| URIGEN PHARMACEUTICALS, INC.
| MEDITOPE BIOSCIENCES, INC.
| CAREDX, INC.
| YOR LABS, INC.
| STIMIT CORP
| COUNSLR, INC.
| MAMS HOLDCO LLC
LOUIS
G.
LANGE
DIRECTOR
DAVID
LEVISON
EXECUTIVE OFFICER, DIRECTOR
ARTHUR
M.
PAPPAS
DIRECTOR
STEVEN
ROSENBERG
EXECUTIVE OFFICER
AJIT
SINGH
DIRECTOR
RISA
STACK
DIRECTOR
JAMES
R.
TOBIN
DIRECTOR
MARK
WEEKS
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
Equity
2017-01-05
D/A
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
Equity
2015-06-17
D
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
Equity
2015-06-17
D
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
Equity
2014-07-19
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

